Free Trial

Auna (AUNA) Competitors

Auna logo
$6.32 +0.08 (+1.28%)
As of 03:58 PM Eastern

AUNA vs. PGNY, NHC, PACS, GRAL, TDOC, AHCO, VRDN, AVAH, PNTG, and CDNA

Should you be buying Auna stock or one of its competitors? The main competitors of Auna include Progyny (PGNY), National HealthCare (NHC), PACS Group (PACS), Grail (GRAL), Teladoc Health (TDOC), AdaptHealth (AHCO), Viridian Therapeutics (VRDN), Aveanna Healthcare (AVAH), The Pennant Group (PNTG), and CareDx (CDNA). These companies are all part of the "healthcare" industry.

Auna vs. Its Competitors

Auna (NYSE:AUNA) and Progyny (NASDAQ:PGNY) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends, community ranking and institutional ownership.

94.9% of Progyny shares are held by institutional investors. 9.4% of Progyny shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Progyny has lower revenue, but higher earnings than Auna. Auna is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Auna$4.35B0.11-$67.90M$0.5810.90
Progyny$1.21B1.52$62.04M$0.5737.81

Auna presently has a consensus target price of $10.70, suggesting a potential upside of 69.30%. Progyny has a consensus target price of $23.45, suggesting a potential upside of 8.84%. Given Auna's higher probable upside, equities analysts clearly believe Auna is more favorable than Progyny.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Auna
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
Progyny
0 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.42

In the previous week, Progyny had 5 more articles in the media than Auna. MarketBeat recorded 10 mentions for Progyny and 5 mentions for Auna. Progyny's average media sentiment score of 0.98 beat Auna's score of -0.21 indicating that Progyny is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Auna
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Progyny
3 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Progyny received 94 more outperform votes than Auna when rated by MarketBeat users. However, 72.73% of users gave Auna an outperform vote while only 70.34% of users gave Progyny an outperform vote.

CompanyUnderperformOutperform
AunaOutperform Votes
8
72.73%
Underperform Votes
3
27.27%
ProgynyOutperform Votes
102
70.34%
Underperform Votes
43
29.66%

Progyny has a net margin of 5.03% compared to Auna's net margin of 0.00%. Progyny's return on equity of 11.36% beat Auna's return on equity.

Company Net Margins Return on Equity Return on Assets
AunaN/A N/A N/A
Progyny 5.03%11.36%7.87%

Auna has a beta of 2.47, indicating that its share price is 147% more volatile than the S&P 500. Comparatively, Progyny has a beta of 1.32, indicating that its share price is 32% more volatile than the S&P 500.

Summary

Progyny beats Auna on 13 of the 18 factors compared between the two stocks.

Get Auna News Delivered to You Automatically

Sign up to receive the latest news and ratings for AUNA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AUNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AUNA vs. The Competition

MetricAunaOffices & clinics of medical doctors IndustryMedical SectorNYSE Exchange
Market Cap$467.76M$1.79B$5.61B$19.87B
Dividend YieldN/AN/A5.28%3.83%
P/E Ratio10.9028.0427.1435.60
Price / Sales0.111.73411.8343.81
Price / CashN/A36.0138.2517.51
Price / BookN/A18.297.064.85
Net Income-$67.90M-$52.07M$3.23B$1.02B
7 Day Performance-2.99%0.55%2.67%1.94%
1 Month Performance-9.13%12.87%8.82%3.02%
1 Year Performance-18.24%64.97%31.44%9.87%

Auna Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AUNA
Auna
3.6379 of 5 stars
$6.32
+1.3%
$10.70
+69.3%
-18.4%$467.76M$4.35B10.9014,958Gap Up
PGNY
Progyny
0.9567 of 5 stars
$21.70
+0.9%
$23.45
+8.1%
-22.8%$1.84B$1.21B37.41310
NHC
National HealthCare
N/A$103.58
-0.5%
N/A+1.2%$1.60B$1.37B12.9812,400Positive News
PACS
PACS Group
3.3501 of 5 stars
$9.83
-0.9%
$34.29
+248.8%
-64.1%$1.50B$3.56B0.0032,433
GRAL
Grail
0.4846 of 5 stars
$37.50
-2.4%
$31.50
-16.0%
N/A$1.35B$130.71M-0.611,360
TDOC
Teladoc Health
3.0165 of 5 stars
$6.88
-0.5%
$9.60
+39.4%
-29.0%$1.21B$2.55B-1.195,100
AHCO
AdaptHealth
3.1337 of 5 stars
$8.75
-2.6%
$13.40
+53.1%
-21.6%$1.21B$3.25B-5.3010,900Positive News
VRDN
Viridian Therapeutics
1.8353 of 5 stars
$13.97
+0.4%
$36.70
+162.7%
+19.5%$1.14B$302K-3.2450Positive News
AVAH
Aveanna Healthcare
0.9918 of 5 stars
$5.47
+2.6%
$5.13
-6.3%
+109.2%$1.07B$2.09B-16.0933,000Trending News
Insider Trade
PNTG
The Pennant Group
3.5822 of 5 stars
$28.83
+0.4%
$35.60
+23.5%
+19.2%$989.61M$748.17M42.405,340Positive News
Analyst Forecast
CDNA
CareDx
3.8061 of 5 stars
$17.08
+0.5%
$30.33
+77.6%
+34.9%$951.03M$346.42M-6.33740Positive News

Related Companies and Tools


This page (NYSE:AUNA) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners